Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interaction

J Allergy Clin Immunol. 2015 Apr;135(4):1063-1065.e5. doi: 10.1016/j.jaci.2014.09.041. Epub 2014 Nov 11.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allopurinol / adverse effects*
  • Drug-Related Side Effects and Adverse Reactions / genetics
  • Drug-Related Side Effects and Adverse Reactions / immunology*
  • HLA-B Antigens / genetics
  • HLA-B Antigens / immunology*
  • Humans
  • Lymphocyte Activation / immunology
  • Pharmacogenetics
  • T-Cell Antigen Receptor Specificity
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism

Substances

  • HLA-B Antigens
  • Allopurinol